Letter to the Editor
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 103480
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103480
How is single-cell RNA sequencing contributing to the advancement of cancer therapeutics?
Keun-Yeong Jeong
Keun-Yeong Jeong, Head Office, Research Center, PearlsInMires, Seoul 07292, South Korea
Author contributions: Jeong KY wrote the original draft; Jeong KY contributed to conceptualization, writing, reviewing and editing; Jeong KY participated in drafting the manuscript; and all authors have read and approved the final version of the manuscript.
Conflict-of-interest statement: This author reports no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Keun-Yeong Jeong, PhD, Assistant Professor, Head Office, Research Center, PearlsInMires, 150, Yeongdeungpo-ro, Yeongdeungpo-gu, Seoul 07292, South Korea. alvirus@naver.com
Received: November 21, 2024
Revised: January 20, 2025
Accepted: January 23, 2025
Published online: April 15, 2025
Processing time: 125 Days and 11 Hours
Core Tip

Core Tip: Tang et al explored the distribution and dynamic changes of cell populations within tumor and adjacent tissues of gastric cancer patients using single-cell RNA sequencing (scRNA-seq). In addition to this study, deeper insight into the potential of scRNA-seq will be possible by incorporating information about selecting anticancer drug candidates with gene screening identified by scRNA-seq and their clinical applications.